Details for Patent: 4,182,763
✉ Email this page to a colleague
Summary for Patent: 4,182,763
Title: | Buspirone anti-anxiety method |
Abstract: | Buspirone hydrochloride is an effective anti-anxiety agent for the palliative treatment of neurotic patients in which symptoms of anxiety are predominant at doses which are without observable effect in either normal individuals or psychotic patients. |
Inventor(s): | Casten; George P. (Evansville, IN), McKinney; Gordon R. (Evansville, IN), Newton; Roger E. (Evansville, IN), Tompkins; E. Crosby (Evansville, IN), Weikel, Jr.; John H. (Mt. Vernon, IN) |
Assignee: | Mead Johnson & Company (Evansville, IN) |
Application Number: | 05/908,597 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 4,182,763
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 4,182,763
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 4729579 | ⤷ Try a Trial | |||
Australia | 526202 | ⤷ Try a Trial | |||
Belgium | 876455 | ⤷ Try a Trial | |||
Germany | 2920739 | ⤷ Try a Trial | |||
Japan | S54163587 | ⤷ Try a Trial | |||
Japan | S611008 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |